Kepivance and pulmonary congestion 
Kepivance and pulmonary congestion Patient Reports February 13, 2012
Kepivance Side Effects Report #4949408-6
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: fluid retention, lung infiltration, mucosal inflammation, oedema, pneumonia
, pulmonary congestion, weight increased. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #4966049-5
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, fluid retention, graft versus host disease, lung infiltration, mucosal inflammation, oedema, pneumonia
, pulmonary congestion, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #4993498-1
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, fluid retention, graft versus host disease, lung infiltration, mucosal inflammation, oedema, pneumonia
, pulmonary congestion, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #4994851-2
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, fluid retention, graft versus host disease, lung infiltration, mucosal inflammation, oedema, pneumonia
, pulmonary congestion, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.